Scientific Analysis
ACTRIS partners with clients to evaluate scientific and preclinical data, identify development priorities, and establish a roadmap for translating cell and gene therapy products into clinical studies.
ACTRIS provides scientific and technical consultation to help clients evaluate existing research findings and define development strategies for cell and gene therapy products. Through a comprehensive review of available data, our team supports the planning of translational activities required for progression into clinical studies.
Key aspects of this service include:
Evaluation of available in vitro and in vivo study findings.
Recommendations for additional studies to assess preclinical safety, toxicity, dosing, route of administration, and product stability.
Review of the competitive landscape, current standards of care, and emerging technologies to support target product profile development and value proposition definition.